U.S. Securities and
Exchange Commission Washington, D.C.
20549 Form 10-Q  [x] QUARTERLY REPORT UNDER SECTION 13 OR 15
(d) OF THE SECURITIES EXCHANGE ACT OF 1934  For the quarter ended September 30, 2009  [ ]
         TRANSITION REPORT UNDER
SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period
from to Commission File No.
333-123774 Fountain Healthy Aging, Inc. (formerly Immureboost, Inc.) (Name of Registrant in its
Charter)  NEVADA 86-1098668 --------------- -------------------- (State or
Other Jurisdiction of (I.R.S. Employer I.D. No.) incorporation or
organization) 2764 Lake Sahara Drive, Suite 111, Las Vegas, NV 89117 (Address
of Principle Executive Offices)  Registrants
Telephone Number:  (604) 331-1459  Immureboost, Inc. (Former name, former address and former
fiscal year, if changed since last report)  Check whether the registrant  (1) filed all reports
required to be filed by section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the Company was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days. (1) Yes
  X       No (2)  Yes  X
      No  Indicate by check mark whether the
registrant has submitted electronically and posted on its corporate Web site, if
any, every Interactive Data File required to be submitted and posted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12
months (or for such shorter period that the registrant was required to submit
and post such files). Yes  [  ] No  [X] Not
required  Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company.  See the definitions of large accelerated filer,
accelerated filer, and smaller reporting company, in Rule 12b-2 of the
Exchange Act.  Large
accelerated filer [
 ] Accelerated
filer [
  ] Non-accelerated
filer [
 ] (Do not check if a smaller reporting company) Smaller
reporting company [X]   1    Indicate
by check mark whether the registrant is a shell company (as defined in Rule12b-2
of the Exchange Act) Yes    [X]
    No  [  ]  (APPLICABLE ONLY TO CORPORATE ISSUERS)  State the number of shares
outstanding of each of the Issuers classes of common equity, as of the latest
practicable date: November 23, 2009:  Common Stock101,950,000
  shares DOCUMENTS
INCORPORATED BY REFERENCE  A description of any Documents
Incorporated by Reference is contained in Item 6 of this report.    2     Fountain Healthy Aging, Inc. (formerly Immureboost, Inc.) TABLE OF
CONTENTS  PART I.
    FINANCIAL INFORMATION PAGE Item 1.  Financial
Statements (unaudited):  Balance Sheets 6  Statements of Operations 7   Statements of Cash Flows 8   Notes to Financial Statements
(unaudited) 9-13  Item 2.  Managements
Discussion and Analysis of Financial Condition and Results of Operation 14  Item 3.  Quantitative and
Qualitative Disclosures About Market Risk 15  Item 4T. Controls and
Procedures 15  PART II.     OTHER INFORMATION  Item 5.
  Exhibits 16 Signatures 17    3    PART
I - FINANCIAL INFORMATION Item
1.   Financial Statements  The
accompanying interim unaudited financial statements of Fountain Healthy Aging,
Inc. (a Nevada corporation) are condensed and, therefore, do not include all
disclosures normally required by accounting principles generally accepted in the
United States of America. These statements should be read in conjunction with
the Company's most recent annual financial statements for the year ended
December 31, 2008, included in a Form10-K filed with the U.S. Securities and
Exchange Commission (SEC) on April 15, 2009. In the opinion of management, all
adjustments necessary for a fair presentation have been included in the
accompanying interim financial statements and consist of only normal recurring
adjustments. The results of operations presented in the accompanying interim
financial statements for the nine months ended September 30, 2009, are not
necessarily indicative of the operating results that may be expected for the
full year ending December 31, 2009.  4


FOUNTAIN HEALTHY AGING, INC. (formerly IMMUREBOOST,
INC.) (A
Development Stage Company)  Unaudited Financial Statements  For
the Three and Nine Months Ended September 30, 2009 and 2008, and
the Period of February 25, 2004 (date of inception) through September 30, 2009


5    FOUNTAIN HEALTHY AGING, INC. (formerly IMMUREBOOST,
INC.) (A Development Stage Company) Balance Sheets  September 30

December 312009

2008(unaudited)AssetsCurrent assets


.Cash
$
                     22

$
                        -Total current assets
22

-Fixed assetsOffice and computer equipment
4,222

4,222Less accumulated depreciation
(4222)

(4,199)Net fixed assets
-

23Total assets
$
                     22

$
                     23Liabilities and Stockholders' DeficitCurrent liabilitiesAccounts payable
$
             49,125

$
             18,460Due to officer  (Note 2)
2,564

-Accrued interest  notes payable (Note 6)
11,571

7,267Accrued interest  related party (Note 6)
776

173Short-term loans (Note 6)
64,494

64,494Notes payable  related party (Notes 2 &
6)
18,950

18,950Note payable  timeshare, current portion (Note
6)
-

3,840Total current liabilities
147,480

113,184Long-term liabilitiesNote payable  timeshare, less current portion
(Note 6)
-

17,598Total long-term liabilities
-

17,598Total liabilities
147,480

130,782Stockholders' deficit (Note 4):Common stock; $.001 par value, 1,000,000,000
sharesauthorized,
101,950,000 and 101,850,000 shares issuedand outstanding Sept.
30, 2009 and Dec. 31, 2008, resp.
101,950

101,850Additional paid-in capital
626,256

601,356Deficit accumulated during development stage
(875,664)

(833,965)Total stockholders' deficit
(147,458)

(130,759)Total liabilities and stockholders' deficit
$
                     22

$
                     23  See
accompanying notes to financial statements.  6


FOUNTAIN HEALTHY AGING, INC. (formerly IMMUREBOOST,
INC.) (A Development Stage Company) Statements of Operations (unaudited) February 25, 2004Three months ended

Nine months ended

(Inception) toSeptember 30,
September 30,

September 30,2009

2008

2009

2008

2009Revenues
$
             -

$
                    -

$
             -

$
                     -

$
              4,000ExpensesGeneral and administrative
expenses
37,751

8,741

58,330

342,919

881,298Net loss from operations
(37,751)

(8,741)

(58,330)

(342,919)

(877,298)Other Income (Expenses)Interest expense
(1,636)

(2,643)

(4,907)

(7,800)

(28,168)Impairment of intangible asset
-

-

-

-

(32,200)Exchange gain
100

-

100

-

100Gain on timeshare foreclosure
-

-

21,438

-

21,438Gain on disposal of assets
-



-



40,464Total other income
(expense)
(1,536)

(2,643)

16,631

(7,800)

1,634Net loss and deficit
accumulated during development stage
$  (39,287)

$
        (11,384)

$  (41,699)

$
       (350,719)

$
      (875,664)Net loss per share
$
     (0.00)

$
            (0.00)

$
     (0.00)

$
             (0.01)Weighted average common
sharesoutstanding,
basic and diluted
101,950000

50,925,000

101,862,500

50,925,000  See accompanying notes to financial statements.


7


FOUNTAIN HEALTHY AGING, INC. (formerly IMMUREBOOST,
INC.) (A Development Stage Company) Statements of Cash Flows (unaudited) February 25, 2004(Inception) toNine Months Ended September
30,

September 30,2009

2008

2009Operating activitiesNet loss
$
         (41,699)

$
         (350,719)

$
           (875,664)Adjustments to reconcile net loss to net
cashused in operations:Depreciation
23

35

4,222Gain on
disposal of assets
-

-

(40,464)Stock
issued for services
-

-

500Impairment
of intangible asset
-

-

32,200Gain on
timeshare foreclosure
(21,438)



(21,438)Changes in operating assets and liabilities:Decrease
in accounts receivable
-

4,216

-Decrease
 in prepaid expense
-

525

-Increase
(decrease)  in accounts payable
30,665

(9,309)

90,490Increase
in accrued compensation  officer
-

309,043

594,153Increase
in due to officer
2,564

-

2,564Increase
in accrued interest  notes payable
4,304

4,633

11,571Increase
in accrued interest  related party
603

1,280

1,629Net cash used in operating activities
(24,978)

(40,296)

(200,237)Investing activitiesPurchase of fixed assets
-

-

(4,222)Net cash used in investing activities
-

-

(4,222)Financing activitiesIssuance of stock for cash
25,000

-

100,400Proceeds from short-term loans
-

34,900

65,737Proceeds from notes payable  related party
-

-

50,950Principal payments on note payable
-

(1,864)

(12,606)Net cash provided by financing activities
25,000

33,036

204,481Net increase (decrease) in cash
22

(7,260)

22Cash at beginning of period
-

7,473

-Cash at end of period
$
                    22

$
               213

$
                     22Supplemental disclosures:Interest paid for in cash
$
                      -

$
            3,272

$
               11,565Income taxes paid for in cash
$
                       -

$
                     -

$
                         -Non-cash investing and financing activities:Purchase of investment property with note
payable
$
                       -

$
                    -

$
               30,104Forgiveness of debt  related party
$
                       -

$
                    -

$
                    300 See accompanying notes to financial statements.  8    FOUNTAIN
HEALTHY AGING, INC. (formerly IMMUREBOOST, INC.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Three and Nine Months Ended
September 30, 2009, and the Period of February 25, 2004
(Inception) through September 30, 2009  1. Organization and Summary of
Significant Accounting Policies This summary of
significant accounting policies of FOUNTAIN HEALTHY AGING, INC. (formerly
IMMUREBOOST, INC.) (a development stage company) (the Company) is presented to
assist in understanding the Company's financial statements. These accounting
policies conform to accounting principles generally accepted in the United
States of America and have been consistently applied in the preparation of the
accompanying financial statements. The Company has realized minimal revenues
from its planned principal business purpose and, accordingly, is considered to
be in its development stage in accordance with Financial Accounting Standards
Board (FASB) Accounting Standards Codification (ASC) Topic No. 915 (SFAS No.
7).  The Company has elected a fiscal year end of December 31. Business
Description FOUNTAIN HEALTHY AGING, INC. is a Nevada corporation
originally organized on February 25, 2004 to acquire timeshares and like
entities and facilitate rentals and sales of the entities and travel packages
via its full-service travel website.    On July 17, 2006, the
Board of Directors voted to change the name of the Company to eSavingStore.com,
Inc.  On June 5, 2007, the Board of Directors voted to change the name of
the Company to Immureboost, Inc.  On August 18, 2007, the Company entered
into an asset purchase agreement with Immureboost Inc., a Thailand company, with
the intention to purchase intellectual property to develop products that affect
the human bodys immune system.  No assets were ever acquired or stock
issued as a result of this agreement, which was terminated.  On August 27, 2008, the Company changed its name to
Fountain Healthy Ageing, Inc.  On September 16, 2008, the Company changed
the spelling to Fountain Healthy Aging, Inc. The Company has established a
relationship with Natural Planet USA LLC, a California LLC (Natural Planet),
under which the Company had acquired rights to distribute a number of anti-aging
products developed by Natural Planet.  The Company is in the process of
developing its business as a pioneering, science-based company that licenses and
distributes effective, natural, and safe products that slow and delay the aging
process and improve the symptoms associated with aging. Income Taxes The Company recognizes the tax effects of
transactions in the year in which such transactions enter into the determination
of net income, regardless of when reported for tax purposes. Deferred taxes are
provided in the financial statements under ASC Topic No. 740 (SFAS No. 109) to
give effect to the resulting temporary differences which may arise from
differences in the bases of fixed assets, depreciation methods, allowances, and
start-up costs based on the income taxes expected to be payable in future years.
Development stage deferred tax assets approximating $306,000 arising as a result
of net operating loss carryforwards totaling $875,664 have been offset
completely by a valuation allowance due to the uncertainty of their utilization
in future periods.   The valuation allowance increased by
approximately $14,600 and $122,800 during the Nine Months Ended September 30,
2009 and 2008, respectively. Estimates Preparation of financial statements in
accordance with accounting principles generally accepted in the United States of
America requires the use of estimates, such as depreciation and valuation of
timeshare points. Because of the use of estimates inherent in the financial
reporting process, actual results could differ significantly from those
estimates.       9    FOUNTAIN
HEALTHY AGING, INC. (formerly IMMUREBOOST, INC.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Three and Nine Months Ended
September 30, 2009, and the Period of February 25, 2004
(Inception) to September 30, 2009  1. Organization and Summary of Significant Accounting
Policies (continued) Fixed Assets Fixed assets are
stated at cost and consist of computers and other office equipment. Depreciation
is computed using the accelerated double-declining method based on estimated
useful lives of 3 years. Cash and
Cash Equivalents For the purpose of the statements of cash
flows, the Company considers all highly liquid debt instruments purchased with a
maturity of Three Months or less to be cash equivalents. The Company had $22 and
$- in cash at September 30, 2009 and December 31, 2008, respectively.  Advertising The Company generally expenses advertising
costs as incurred. No advertising costs were incurred during the period of
February 25, 2004 (inception) through September 30, 2009. Revenue
Recognition  As described in Note 3, the Company has
acquired an interest in a timeshare property. Revenues were originally intended
to be recognized upon sale of timeshare points redeemable for utilization of the
property, or when the Company performs other travel related services. The
Company has recognized minimal revenue of $4,000 from its initial intended
business purpose since inception through September 30, 2009.  The Company has established a relationship
with Natural Planet USA LLC, a California LLC (Natural Planet), under which
the Company had acquired rights to distribute a number of anti-aging products
developed by Natural Planet.  The Company is in the process of developing
its business as a pioneering, science-based company that licenses and
distributes effective, natural, and safe products that slow and delay the aging
process and improve the symptoms associated with aging.  As such, the
Company is evaluating its revenue-generating opportunities and will establish a
revenue recognition policy once these opportunities have been determined. Earnings (Loss) Per Share The computation of net income (loss) per
share of common stock is based on the weighted average number of shares
outstanding during the period presented. There were no potentially dilutive
common share equivalents outstanding during the periods shown and, accordingly,
the computation of net loss per share on a fully dilutive basis is the same as
basic net loss per share. 2.  Related Party
Transactions On April 22, 2004,
the Company entered into a consulting agreement with an entity affiliated with
its former president/director. The entity was engaged to perform consulting
services and provide office space for the Company for a term of six months
commencing April 22, 2004, in exchange for $15,000. On December 30, 2004, the
president/director resigned from his position with the Company. For the period of February 25, 2004
(inception) through April 22, 2004 (see above paragraph), and for the period of
July 2006 to the present, office space and services have been provided without
charge by the Company's CEO. Such costs are not significant to the financial
statements and have not been reflected therein.      10    FOUNTAIN
HEALTHY AGING, INC. (formerly IMMUREBOOST, INC.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Nine Months Ended September 30,
2009 2.  Related Party
Transactions (continued) In February 2007, the Companys then sole
Officer (the Former Officer) loaned the Company $300 to pay for operating
expenses.  Upon the resignation from his positions with the Company
effective August 28, 2008, the Former Officer forgave the amounts owed to him.
 The Company has written off the debt to additional paid-in capital.  On July 6, 2007, the Company entered into
an employment agreement with the Officer, whereby the Officer would perform
various services for the Company in exchange for annual Officer compensation of
300,000 Euros, plus 100,000 Euros for annual Director's fees.  The
compensation was translated from Euros into US dollars using a weighted average
exchange rate pro-rated for the period of July 2007 through June 2008, resulting
in $156,266 compensation expense for the nine months ended September 30, 2008,
and total accrued compensation of $592,873 at September 30, 2008.  The
agreement also entitled the Officer to stock options pursuant to a separate
agreement, which was never executed.  In August 2008, the Officer resigned
from his positions with the Company and released all claims he had against the
Company for debts owed to him. Thus, $592,873 in accrued compensation and
$32,000 in notes payable (plus $2,133 in accrued interest) from 2007 were
written off to additional paid-in capital during the quarter ended September 30,
2008.  In August 2008, a company affiliated with the Companys
CEO advanced the Company $8,400.  In November and December 2008, the
Companys CEO advanced the Company $10,550.  The notes total $18,950, carry
an interest rate of 4.25%, and are due on demand (See Note 6).  During the quarter ended September 30, 2009, the
Companys CEO incurred $2,564 in reimbursable expenses incurred in the Companys
behalf, on which interest has not been imputed due to its immaterial affect on
the financials. 3.  Intangible Asset and
Note Payable  Timeshare Shortly after
inception, the Company acquired an undivided interest in the Wyndham Vacation
Resorts (formerly Fairfield Resorts, Inc.) (WVR) timeshare resort, along with
the rights to participate in timeshare use, or to allow certain others the use,
of a specified number of days lodging in WVR timeshare properties. The timeshare
interest was being financed by WVR, but the Company defaulted on its payments
during 2008, which compelled WVR to foreclose on the mortgage and revoke the
timeshare interest.  In light of the Companys new business direction, the
Company had been seeking to dispose of the intangible asset.  As a result,
the carrying value of the asset was impaired down to $0 during the fourth
quarter of 2008.   Upon foreclosure in March 31, 2009, the loan had a
carrying value of $21,438, which has been included in other income on the
statement of operations. 4.  Stockholders' Deficit The Board of
Directors authorized a 30:1 forward stock split on July 1, 2006, a 2:1 reverse
stock split on June 12, 2007, and a 2:1 forward split on December 22, 2009.
 These footnotes and the accompanying financial statements have been
retroactively restated to include the effects of the splits.  The following
transactions comprise the 101,950,000 and 101,850,000 shares of common stock
issued and outstanding at September 30, 2009 and December 31, 2008,
respectively. During March and April 2004, the Company issued common
stock for cash in accordance with separate private offering memorandums as
follows: Number of
shares Price
per share Cash received 27,000,000 $ .0000335 $ 900 28,500,000 .000335 9,500 30,000,000 .001 30,000 11,400,000 .00165 19,000 4,800,000 .00335 16,000 101,700,000 $ 75,400  11     FOUNTAIN HEALTHY AGING, INC. (formerly
IMMUREBOOST, INC.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Three and Nine Months Ended
September 30, 2009, and the Period of February 25, 2004
(Inception) to September 30, 2009  4.  Stockholders' Equity
(continued) Pursuant to a Form 8-K filed with the SEC
on July 28, 2006, the Board of Directors voted to increase the Companys
authorized common shares from 75,000,000 to 1,000,000,000 shares.  On October 1, 2006, the Company issued
150,000 shares of common stock at $.00335 per share to its transfer agent for
$500 in services.  On July 4 and July 14, 2009, the Company
issued to two unaffiliated investors, 100,000 total shares of common stock at
$.25 per share for $25,000 in cash.  5.  Going Concern and Liquidity
Considerations The accompanying
financial statements have been prepared assuming that the Company will continue
as a going concern, which contemplates, among other things, the realization of
assets and satisfaction of liabilities in the normal course of business.
 As of September 30, 2009, the Company has a working capital deficit of
$147,480 and an accumulated deficit of $875,664.  Unanticipated costs and
expenses or the inability to generate revenues could require additional
financing, which would be sought through bank borrowings, equity or debt
financing, or asset sales. To the extent financing is not available, the Company
may not be able to, or may be delayed in, developing its services and meeting
its obligations. The Company will
continue to evaluate its projected expenditures relative to its available cash
and to evaluate additional means of financing in order to satisfy its working
capital and other cash requirements. The accompanying financial statements do
not reflect any adjustments that might result from the outcome of these
uncertainties.  6. Notes Payable Principal balanceSeptember 30

December 31,2009

2008Note Payable Ttimeshare:Wyndham Vacation Resorts (WVR) (Note 3) for $33,100
 June 2004 inception, June 2014 maturity, $415 monthly payments, 10.99%
annual interest, collateralized by the timeshare property.  Interest
expense of $0 and $683 for the three months ended March 31, 2009 and 2008,
respectively, with no accrued interest at March 31, 2009 or December 31,
2008.  During the current quarter, WVR repossessed the timeshare and
voided the contract.
$
                  -

$
        21,438Notes PayableIndependent investor for $22,994  March 2007
inception, September 2007 maturity, 5.25% annual interest plus 1% interest
per month late fee each month after maturity, unsecured.  Interest
expense of $1,811 and $2,199 for the nine months ended September 30, 2009
and 2008, respectively.  Accrued interest of $6,137 and $4,326 at
September 30, 2009 and December 31, 2008, respectively.
22,994

22,994Independent investor for $15,000  November 2007
inception, due on demand, 8% annual interest, unsecured.  Interest
expense of $903 and $900 for the nine months ended September 30, 2009 and
2008, respectively.  Accrued interest of $2,254 and $1,351 at
September 30, 2009 and December 31, 2008, respectively.
15,000

15,000  12       FOUNTAIN HEALTHY AGING, INC.
(formerly IMMUREBOOST, INC.)
(A Development Stage
Company)
Notes to Financial Statements
(unaudited)
For the Three and Nine Months Ended
September 30, 2009,
and the Period of February 25, 2004
(Inception) to September 30, 2009

7.
Notes Payable
(continued)Independent investors for $26,500  April 2008, due
on demand, 8% annual interest, unsecured.  Interest expense of $1,590
and $1,060 for the nine months ended September 30, 2009 and 2008,
respectively.  Accrued interest of $3,180 and $1,590 at September 30,
2009 and December 31, 2008, respectively.
26,500

26,500Total Notes
Payable
64,494

64,494Notes Payable  Related
Parties:Company affiliate  August 2008, due on demand,
4.25% annual interest, unsecured.  Interest expense of $267 for the
nine months ended September 30, 2009.  Accrued interest of $404 and
$137 at September 30, 2009 and December 31, 2008, respectively.
8,400

8,400Company Officer  November and December 2008, due
on demand, 4.25% annual interest, unsecured.  Interest expense of
$336 and $36 for the nine months ended September 30, 2009.  Accrued
interest of $372 and $36 at September 30, 2009 and December 31, 2008,
respectively.
10,550

10,550Total Notes Payable 
Related Parties
18,950

18,950Total notes payable
83,444

104,882Less current portion
83,444

87,284Total notes payable  long-term
$
                  -

$
        17,598       13    Item 2.
 Managements Discussion and Analysis of Financial Condition and Results of
Operations.  Fountain Healthy Aging, Inc. (formerly Immureboost, Inc.)
was incorporated in the State of Nevada on February 25, 2004.  Since its
inception, the Company has not been involved in any bankruptcy, receivership or
similar proceedings.  It has not undergone any material reclassification,
merger, consolidation, or purchase or sale of a significant amount of assets in
the ordinary course of business.  GENERAL  Prior to August 18, 2007, the Company was in the business
of providing travel bookings and timeshare rentals and sales. Fountain Healthy
Aging, Inc. (formerly Immureboost, Inc) was formed on February 25, 2004, under
the name Celtic Cross, Ltd. as a For Profit corporation for the purpose of
acquiring the timeshare entities discussed herein, and additional like entities
going forward including a full sales and service website.  The Company has
elected a fiscal year end of December 31.  On July 17, 2006, the Board of Directors voted to change
the name of the Company to eSavingStore.com, Inc. to more accurately reflect the
Companys business plan.  On July 5, 2007, the stockholders of the Company
approved the name change to Immureboost, Inc.  On August 27, 2008, the
Company changed its name to Fountain Healthy Aging, Inc.  On August 18,
2007, the Company entered into an Asset Purchase Agreement (Agreement) with
Immureboost of Thailand, a Thai corporation (the "Seller") which develops
processes, products, and pharmaceuticals that interact with the immune system.
Under the terms of the Agreement, the Company would have acquired certain assets
of the Seller, including patents and trademarks. In consideration of these
assets, certain stockholders of the Seller would have received twenty million
three hundred seventy thousand (20,370,000) "restricted shares" (as that term is
defined in Rule 144 of the Securities Act of 1933; the "Act") of the
Company's Common Stock.  No assets were ever acquired or stock issued as a
result of this agreement, which was declared terminated on or about August 19,
2008 During the final quarter of 2008,
the Company established a relationship with Natural Planet USA, Inc. (formerly
Natural Planet USA), a California corporation (Natural Planet), under which
the Company will acquire rights to distribute a number of anti-aging products
developed by Natural Planet.  The Company is in the process of developing
its business as a pioneering, science-based company that licenses and
distributes effective, natural and safe products that slow and delay the aging
process and improve the symptoms associated with aging. On September 14, 2009, the Company entered into an
agreement to acquire the entire outstanding stock of Natural Planet on a date to
be agreed between the Company and the shareholders of Natural Planet.  As
at September 30, 2009, this acquisition had not been completed.  The
acquisition will be completed upon the payment of the purchase price by the
Company to the shareholders of Natural Planet. In June of 2004, the Company
acquired an undivided interest in the Wyndham Vacation Resorts (formerly
Fairfield Resorts, Inc.) (WVR) timeshare resort, along with the rights to
participate in timeshare use, or to allow certain others the use, of a specified
number of days lodging in WVR timeshare properties. The purchase price of
$33,100 was being financed by WVR at 10.99% annual interest on a ten-year loan.
The maintenance at the WVR facilities are the responsibility of WVR, however,
the Company had previously paid a monthly fee to WVR for this service. The
Company was unable to maintain the loan and maintenance payments and was
unsuccessful in its attempts to sell this interest.  During the first
quarter of 2009, WVR foreclosed on the loan and reclaimed the timeshare
interest.  RESULTS OF OPERATIONS The Company has generated $4,000 in revenues since
inception, and has an accumulated deficit of $875,664.  During the three
months ended September 30, 2009 and 2008, we incurred $37,751 and $8,741 in
operating expenses and during the nine months ended September 30, 2009 and 2008,
we incurred $58,330 and $342,919 in operating expenses. The decrease in
operating expenses was due to the departure of Mr. Steven Burke, a former
officer with whom the Company had a compensation arrangement resulting
approximately $590,000 in compensation expense during the term of the
arrangement of July 2007 through June 2008.  At September 30, 2009, we had
current assets of $22 and current liabilities of $147,480.     14    LIQUIDITY. During the next 12 months, the
Company will need significant working capital to fund its research efforts and
meet its current debt obligations. The Company intends to obtain working capital
either from the sale of product or through private investments made by third
parties or debt instruments.  Item 3. Quantitative and Qualitative
Disclosures About Market Risk  Not required by smaller reporting companies.  Item 4T. Controls and Procedures  Evaluation of Disclosure Controls and
Procedures Our management is responsible for
establishing and maintaining adequate internal control over financial reporting.
Our internal control over financial reporting is a process designed to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes of accounting
principles generally accepted in the United States.  Because of its
inherent limitations, internal control over financial reporting may not prevent
or detect misstatements. Therefore, even those systems determined to be
effective can provide only reasonable assurance of achieving their control
objectives. Because of the inherent limitations of internal control, there is a
risk that material misstatements may not be prevented or detected on a timely
basis by internal control over financial reporting.  However, these
inherent limitations are known features of the financial reporting process.
 Therefore, it is possible to design into the process safeguards to reduce,
though not eliminate this risk.  As of September 30, 2009, management
assessed the effectiveness of our internal control over financial reporting.
 Based on that evaluation, they concluded that, during the period covered
by this report, such internal controls and procedures were not effective to
detect the inappropriate application of US GAAP rules.  The determination
of ineffective internal control is based upon the lack of separation of duties.
In evaluating the effectiveness of our internal control over financial
reporting, our management used the criteria set forth by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control
 Integrated Framework.  Under the supervision and with the
participation of our senior management, including our chief executive officer
and chief financial officer, Paul Hunston, we conducted an evaluation of the
effectiveness of the design and operation of our disclosure controls and
procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934, as amended (the Exchange Act), as of the end of the
period covered by this quarterly report (the Evaluation Date). Based on this
evaluation, our chief executive officer and chief financial officer concluded as
of the Evaluation Date that our disclosure controls and procedures were not
effective such that the information relating to us required to be disclosed in
our Securities and Exchange Commission (SEC) reports (i) is recorded,
processed, summarized and reported within the time periods specified in SEC
rules and forms, and (ii) is accumulated and communicated to our management,
including our chief executive officer and chief financial officer, as
appropriate to allow timely decisions regarding required disclosure.  Officers Certifications  Appearing as exhibits to this quarterly
report are Certifications of our Chief Executive Officer and Chief Financial
Officer. The Certifications are required pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002 (the Section 302 Certifications). This section of
the Quarterly Report contains information concerning the Controls Evaluation
referred to in the Section 302 Certification. This information should be read in
conjunction with the Section 302 Certifications for a more complete
understanding of the topics presented.  Changes in Internal Control Over
Financial Reporting  There have been no changes in our internal
control over financial reporting that occurred during the quarter ended
September 30, 2009 that have materially affected or are reasonably likely to
materially affect our internal control over financial reporting.  15     PART II - OTHER INFORMATION   Item 5. Exhibits.  The following exhibits are filed
herewith: 31.1 Certification pursuant to
Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as
amended. 32.1 Certification pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.      16    SIGNATURES Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned thereunto duly authorized. FOUNTAIN HEALTHY AGING,
INC. Name

Title

DatePaul Hunston

CFO, CEO Director

November 23, 2009   17